Alzheimer’s disease: a selection of recent research into biomarkers and genetic factors

Alzheimer’s disease is the most common cause of dementia, presenting as a gradual decline in memory, thinking, behaviour and social skills. New tests might be able to diagnose the disease when symptoms are very mild, so that the latest therapeutic advances in the field can be applied. Here, Pathology in Practice Science Editor Brian Nation compiles a small selection of current research interest.

Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs

Monteiro AR, Barbosa DJ, Remião F, Silva R. Biochem Pharmacol. 2023 May; 211: 115522. doi: 10.1016/j.bcp.2023.115522.

Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative diseases that affect millions of people worldwide, with both prevalence and incidence increasing with age. It is characterised by cognitive decline associated, specifically, with degeneration of cholinergic neurons. 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024